Cargando…
Comparable Effects of Strontium Ranelate and Alendronate Treatment on Fracture Reduction in a Mouse Model of Osteogenesis Imperfecta
Alendronate (Aln) has been the first-line drug for osteogenesis imperfecta (OI), while the comparable efficacy of Aln and strontium ranelate (SrR) remains unclear. This study is aimed at comparing the effects of SrR and Aln treatment in a mouse model of OI. Three-week-old oim/oim and wt/wt female mi...
Autores principales: | Shi, Changgui, Sun, Bin, Ma, Chao, Wu, Huiqiao, Chen, Rui, He, Hailong, Zhang, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810565/ https://www.ncbi.nlm.nih.gov/pubmed/33506016 http://dx.doi.org/10.1155/2021/4243105 |
Ejemplares similares
-
Irisin reduces bone fracture by facilitating osteogenesis and antagonizing TGF-β/Smad signaling in a growing mouse model of osteogenesis imperfecta()()
por: Sun, Bin, et al.
Publicado: (2022) -
Strontium ranelate and alendronate have differing effects on distal tibia bone microstructure in women with osteoporosis
por: Rizzoli, René, et al.
Publicado: (2010) -
The Effect of Strontium Ranelate on Fracture Healing: An Animal Study
por: Koukou, Ourania I., et al.
Publicado: (2020) -
Polymeric strontium ranelate nonahydrate
por: Stahl, Kenny, et al.
Publicado: (2011) -
Cardiac concerns associated with strontium ranelate
por: Reginster, Jean-Yves
Publicado: (2014)